We are live on
!
Find out more
MAM
Martingale Asset Management Portfolio holdings
AUM
$3.99B
1-Year Est. Return
22.65%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+22.65%
3 Year Est. Return
+77.2%
5 Year Est. Return
+114.11%
10 Year Est. Return
+351.19%
AUM
$7.81B
AUM Growth
+$159M
(+2.1%)
Cap. Flow
-$656M
Cap. Flow
% of AUM
-8.4%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
928
New
89
Increased
228
Reduced
448
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AvalonBay Communities
AVB
|
+$33.9M |
| 2 |
Cisco
CSCO
|
+$27.4M |
| 3 |
Exelon
EXC
|
+$19.9M |
| 4 |
Ingredion
INGR
|
+$19.2M |
| 5 |
VMW
VMware, Inc
VMW
|
+$18.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$50.8M |
| 2 |
FedEx
FDX
|
+$36.1M |
| 3 |
Hormel Foods
HRL
|
+$32M |
| 4 |
Visa
V
|
+$29.3M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.54% |
| 2 | Healthcare | 19% |
| 3 | Consumer Staples | 12.12% |
| 4 | Industrials | 9.25% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
CVS Health
CVS
$126B
| $280K | ﹤0.01% |
2,705
+71
| +3% | +$6.56K |
|
|
BLUE
752
DELISTED
bluebird bio
BLUE
| $279K | ﹤0.01% |
1,396
-736
| -35% | -$174K |
|
|
PCSB
753
DELISTED
PCSB Financial Corporation
PCSB
| $279K | ﹤0.01% |
14,609
+100
| +0.7% | +$1.87K |
|
|
CCRD
754
DELISTED
CoreCard
CCRD
| $277K | ﹤0.01% |
7,104
| – | – |
|
755
Erie Indemnity
ERIE
$13.1B
| $277K | ﹤0.01% |
1,432
-12,471
| -90% | -$2.51M |
|
|
AGR
756
DELISTED
Avangrid, Inc.
AGR
| $275K | ﹤0.01% |
5,500
-15,073
| -73% | -$764K |
|
757
Vishay Precision Group
VPG
$978M
| $268K | ﹤0.01% |
7,202
| – | – |
|
|
STXB
758
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $260K | ﹤0.01% |
9,000
-23,128
| -72% | -$612K |
|
759
Sierra Bancorp
BSRR
$528M
| $259K | ﹤0.01% |
9,507
+1,000
| +12% | +$25.9K |
|
|
MASI
760
DELISTED
Masimo
MASI
| $259K | ﹤0.01% |
882
| – | – |
|
761
Crawford & Co Class A
CRD.A
$627M
| $258K | ﹤0.01% |
34,337
-10,503
| -23% | -$86.7K |
|
762
Douglas Elliman
DOUG
$159M
| $255K | ﹤0.01% |
+23,208
| New | +$261K |
|
763
Peoples Financial Services
PFIS
$716M
| $254K | ﹤0.01% |
4,805
| – | – |
|
764
Lands' End
LE
$393M
| $252K | ﹤0.01% |
12,788
+1,104
| +9% | +$25.7K |
|
|
OLP
765
One Liberty Properties
OLP
$520M
| $252K | ﹤0.01% |
7,118
-4,046
| -36% | -$134K |
|
766
Lifecore Biomedical
LFCR
$167M
| $250K | ﹤0.01% |
22,514
+100
| +0.4% | +$970 |
|
767
FS Bancorp
FSBW
$323M
| $249K | ﹤0.01% |
7,392
-4,650
| -39% | -$159K |
|
768
US Physical Therapy
USPH
$1.18B
| $249K | ﹤0.01% |
2,600
+300
| +13% | +$30.1K |
|
769
Workday
WDAY
$42.1B
| $247K | ﹤0.01% |
+901
| New | +$250K |
|
770
Agilent Technologies
A
$39.9B
| $246K | ﹤0.01% |
1,539
| – | – |
|
771
Safe Bulkers
SB
$778M
| $245K | ﹤0.01% |
+64,895
| New | +$265K |
|
|
TCRR
772
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $244K | ﹤0.01% |
+52,234
| New | +$327K |
|
|
NFBK
773
DELISTED
Northfield Bancorp
NFBK
| $241K | ﹤0.01% |
14,900
| – | – |
|
|
OYST
774
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $240K | ﹤0.01% |
13,106
| – | – |
|
775
The RMR Group
RMR
$324M
| $238K | ﹤0.01% |
+6,819
| New | +$236K |
|
Similar funds
GCM
USCWA
AI
LWCA
JSW
BWA
AS
BCP
Martingale Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Martingale Asset Management held 928 positions worth $7.81B, up 2.1% from $7.65B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Martingale Asset Management withdrew a net $656M in Q4 2021, closing 114 positions and reducing 448 holdings. Its most notable exit was Acceleron Pharma, an estimated $23.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Martingale Asset Management opened a new position in Northern Trust worth $14M.
- Martingale Asset Management's largest Q4 2021 buy was Northern Trust: 116,900 shares worth $14M.
- Martingale Asset Management added most to AvalonBay Communities in Q4 2021, an estimated $33.9M increase.
- Martingale Asset Management's biggest Q4 2021 reduction was Stryker, cutting an estimated $50.8M.
- Martingale Asset Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $23.2M.
- Martingale Asset Management's ten largest holdings make up 13% of its $7.81B portfolio in Q4 2021.
- Martingale Asset Management opened 89 new positions and closed 114 in Q4 2021.
- Martingale Asset Management's portfolio value rose 2.1% quarter-over-quarter to $7.81B.
Based on Martingale Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.